While activating mutations in RAS or epidermal growth factor receptor (EGFR) are the most common drivers of NSCLC, oncogenic fusions created by chromosome translocations are also frequent driver events (Yuan et al, 2019). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.